根据该协议,Karveer有权在印度将公司的COVID药物NV-CoV-2和NV-CoV-2-R商业化。为了实现商业化,Karveer已经进行了临床开发和评估,并为此在印度赞助了这两种药物。
蹊之美股生物医药2021-09-23 23:00
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Aethlon Medical (NASDAQ:AEMD) +33%
Onconova Therapeutics (NASDAQ:ONTX) +28%
Dynavax Technologies (NASDAQ:DVAX) +26%
Candel Therapeutics (NASDAQ:CADL) +18%
BioCardia ...查看全文
蹊之美股生物医药2021-07-29 21:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Infinity Pharmaceuticals (NASDAQ:INFI) +62%
Tilray (NASDAQ:TLRY) +25%
Grove (NASDAQ:GRVI)+20%
NeuroMetrix (NASDAQ:NURO) +2%
成纤维细胞生长因子3是一种在多种肿瘤类型,尤...查看全文
智通财经APP获悉,NanoViricides(NNVC.US)周四表示,该公司已经开始研发对抗猴痘病毒的药物。受此消息提振,截至发稿,NanoViricides周四美股盘前暴涨47.97%,报3.64美元。 NanoViricides是一家基于新型纳米药物平台开发高效抗病毒疗法... 网页链接
$NanoViricides(NNVC)$ 8-K Current report, item 5.02 Accession Number: 0001104659-20-069859 Act: 34 Size: 14 KB 网页链接
$NanoViricides(NNVC)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-20-067429 Act: 34 Size: 96 KB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-20-065358 Act: 34 Size: 328 KB 网页链接
$NanoViricides(NNVC)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001104659-20-064991 Act: 33 Size: 1 MB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, items 5.02 and 9.01 Accession Number: 0001104659-20-063847 Act: 34 Size: 224 KB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, item 8.01 Accession Number: 0001104659-20-061689 Act: 34 Size: 28 KB 网页链接
$NanoViricides(NNVC)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-20-055415 Size: 2 KB 网页链接
$NanoViricides(NNVC)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-20-000674 Act: 33 Size: 1 KB 网页链接
$NanoViricides(NNVC)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-20-037812 Act: 33 Size: 1 MB 网页链接
$NanoViricides(NNVC)$ 8-K Current report, items 5.03, 5.07, and 9.01 Accession Number: 0001104659-20-036792 Act: 34 Size: 569 KB 网页链接